Filing Details
- Accession Number:
- 0001209191-11-045496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-24 16:58:37
- Reporting Period:
- 2011-08-22
- Filing Date:
- 2011-08-24
- Accepted Time:
- 2011-08-24 16:58:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1357396 | George Spiro Rombotis | 200 Connell Drive Suite 1500 Berkeley Heights NJ 07922 | President & C.e.o. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2011-08-22 | 9,232 | $0.73 | 567,430 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Of the shares of common stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account and 15,618 shares are represented by unvested restricted stock units.